Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

NCT06349408 is registered in ClinicalTrials.gov with Fortvita Biologics (USA)Inc. as lead sponsor.

NCT NCT06349408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06349408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
Lead sponsor
Fortvita Biologics (USA)Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
January 10, 2025
Completion date
December 31, 2027
Enrollment
250 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced solid tumor